More than 100 patients have been seriously injured as a result of a significant safety concern. The Impella devices can still be used, according to the recall, if customers refer to Abiomed's new and revised instructions for use.

Kumar Madassery, MD, detailed some of the techniques and tools used to restore blood flow to the foot to help foot wounds heal and prevent amputation.

A team of specialists in Houston made history, using the new-look device to treat three patients over the age of 80. The group shared its experience in JACC: Clinical Electrophysiology.

When Boston Scientific’s coronary DCB gained approval in the United States, it was a moment the country's cardiologists had been looking forward to for years. The cardiologists who researched the device have now detailed their findings, highlighting the "unmet need" this technology is addressing. 

The shields can significantly reduce radiation exposure, according to cardiologist David G. Rizik, MD. He said they also allow cardiologists, nurses and other cath lab employees to provide care without wearing lead aprons. 

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

New data out of Germany suggest TMVR can offer intermediate-risk patients a safe alternative to surgery.

Ken Rosenfield, MD, of Massachusetts General Hospital, and William Gray, MD, of Lankenau Heart Institute, detailed the long-term impact of a key policy shift.